InspireMD, Inc. (NSPR)
USD 2.53
(-5.87%)
USD 2.53
(-5.87%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2023 | -19.91 Million USD | -7.71% |
| 2022 | -18.49 Million USD | -23.95% |
| 2021 | -14.91 Million USD | -41.48% |
| 2020 | -10.54 Million USD | -5.02% |
| 2019 | -10.04 Million USD | -38.67% |
| 2018 | -7.24 Million USD | 14.2% |
| 2017 | -8.43 Million USD | 0.27% |
| 2016 | -8.46 Million USD | 45.71% |
| 2015 | -15.58 Million USD | 37.9% |
| 2014 | -25.09 Million USD | 14.23% |
| 2013 | -29.25 Million USD | -66.27% |
| 2012 | -17.59 Million USD | -19.99% |
| 2011 | -14.66 Million USD | -61065.33% |
| 2010 | -23.97 Thousand USD | -526.82% |
| 2009 | -3825.00 USD | 0.0% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 Q2 | -7.9 Million USD | -12.47% |
| 2024 Q1 | -7.03 Million USD | -30.1% |
| 2023 Q1 | -4.13 Million USD | 14.74% |
| 2023 Q3 | -5.17 Million USD | -1.99% |
| 2023 Q4 | -5.4 Million USD | -4.38% |
| 2023 FY | -19.91 Million USD | -7.71% |
| 2023 Q2 | -5.07 Million USD | -22.9% |
| 2022 Q4 | -4.84 Million USD | -8.93% |
| 2022 Q1 | -4.47 Million USD | -9.25% |
| 2022 FY | -18.49 Million USD | -23.95% |
| 2022 Q2 | -4.59 Million USD | -2.57% |
| 2022 Q3 | -4.44 Million USD | 3.11% |
| 2021 Q2 | -3.5 Million USD | -8.14% |
| 2021 Q4 | -4.09 Million USD | -0.64% |
| 2021 FY | -14.91 Million USD | -41.48% |
| 2021 Q1 | -3.24 Million USD | 15.83% |
| 2021 Q3 | -4.07 Million USD | -16.08% |
| 2020 Q3 | -2.23 Million USD | 9.96% |
| 2020 FY | -10.54 Million USD | -5.02% |
| 2020 Q1 | -1.97 Million USD | 22.64% |
| 2020 Q2 | -2.48 Million USD | -25.38% |
| 2020 Q4 | -3.85 Million USD | -72.55% |
| 2019 Q3 | -2.07 Million USD | 6.17% |
| 2019 Q2 | -2.2 Million USD | 31.21% |
| 2019 Q1 | -3.2 Million USD | -44.92% |
| 2019 FY | -10.04 Million USD | -38.67% |
| 2019 Q4 | -2.55 Million USD | -23.53% |
| 2018 Q2 | -627 Thousand USD | 73.75% |
| 2018 Q4 | -2.21 Million USD | -10.04% |
| 2018 Q3 | -2.01 Million USD | -220.73% |
| 2018 FY | -7.24 Million USD | 14.2% |
| 2018 Q1 | -2.38 Million USD | -59.27% |
| 2017 Q3 | -2.08 Million USD | 9.07% |
| 2017 Q4 | -1.5 Million USD | 28.09% |
| 2017 FY | -8.43 Million USD | 0.27% |
| 2017 Q1 | -2.55 Million USD | -12.83% |
| 2017 Q2 | -2.29 Million USD | 10.36% |
| 2016 Q4 | -2.26 Million USD | -13.0% |
| 2016 FY | -8.46 Million USD | 45.71% |
| 2016 Q1 | -2.6 Million USD | 8.58% |
| 2016 Q3 | -2 Million USD | -1.36% |
| 2016 Q2 | -1.98 Million USD | 24.11% |
| 2015 FY | -15.58 Million USD | 37.9% |
| 2015 Q3 | -3.64 Million USD | 6.11% |
| 2015 Q4 | -2.85 Million USD | 21.61% |
| 2015 Q2 | -3.87 Million USD | 25.59% |
| 2015 Q1 | -5.21 Million USD | -8.81% |
| 2014 Q2 | -7.56 Million USD | -26.71% |
| 2014 Q3 | -6.77 Million USD | 10.41% |
| 2014 FY | -25.09 Million USD | 14.23% |
| 2014 Q1 | -5.96 Million USD | 0.0% |
| 2014 Q4 | -4.79 Million USD | 29.3% |
| 2013 Q2 | -14.94 Million USD | -205.98% |
| 2013 Q1 | -4.88 Million USD | -154.43% |
| 2013 FY | -29.25 Million USD | -66.27% |
| 2013 Q4 | - USD | 100.0% |
| 2013 Q3 | -3.94 Million USD | 73.61% |
| 2012 Q2 | -3.94 Million USD | -25.51% |
| 2012 Q1 | -3.14 Million USD | 61.86% |
| 2012 FY | -17.59 Million USD | -19.99% |
| 2012 Q4 | -1.92 Million USD | 74.42% |
| 2012 Q3 | -7.5 Million USD | -90.46% |
| 2011 Q1 | -1.89 Million USD | -72925.05% |
| 2011 FY | -14.66 Million USD | -61065.33% |
| 2011 Q4 | -8.23 Million USD | -260.62% |
| 2011 Q3 | -2.28 Million USD | -1.29% |
| 2011 Q2 | -2.25 Million USD | -18.94% |
| 2010 Q4 | -2595.00 USD | 48.1% |
| 2010 FY | -23.97 Thousand USD | -526.82% |
| 2010 Q3 | -5000.00 USD | 54.19% |
| 2010 Q2 | -10.91 Thousand USD | -188.3% |
| 2010 Q1 | -3786.00 USD | -41.27% |
| 2009 Q1 | -100.00 USD | 0.0% |
| 2009 Q2 | -225.00 USD | -125.0% |
| 2009 Q3 | -6595.00 USD | -2831.11% |
| 2009 FY | -3825.00 USD | 0.0% |
| 2009 Q4 | -2680.00 USD | 59.36% |
| Name | Net Income | Net Income Difference |
|---|---|---|
| Accelerate Diagnostics, Inc. | -61.61 Million USD | 67.678% |
| BrainsWay Ltd. | -4.19 Million USD | -374.529% |
| Cerus Corporation | -37.48 Million USD | 46.875% |
| Envoy Medical, Inc. | -29.9 Million USD | 33.409% |
| electroCore, Inc. | -18.83 Million USD | -5.745% |
| Helius Medical Technologies, Inc. | -8.85 Million USD | -125.04% |
| IceCure Medical Ltd | -14.65 Million USD | -35.927% |
| Inogen, Inc. | -102.44 Million USD | 80.56% |
| OrthoPediatrics Corp. | -20.97 Million USD | 5.044% |
| Lucid Diagnostics Inc. | -52.66 Million USD | 62.184% |
| Monogram Orthopaedics, Inc. | -13.74 Million USD | -44.894% |
| MaxCyte, Inc. | -37.92 Million USD | 47.483% |
| NeuroOne Medical Technologies Corporation | -11.85 Million USD | -67.933% |
| Nexalin Technology, Inc. | -4.64 Million USD | -328.42% |
| Orthofix Medical Inc. | -151.39 Million USD | 86.845% |
| PAVmed Inc | -64.17 Million USD | 68.966% |
| Rapid Micro Biosystems, Inc. | -52.46 Million USD | 62.041% |
| RxSight, Inc. | -48.6 Million USD | 59.027% |
| Sight Sciences, Inc. | -55.54 Million USD | 64.146% |
| SI-BONE, Inc. | -43.33 Million USD | 54.043% |
| TELA Bio, Inc. | -46.66 Million USD | 57.32% |
| Treace Medical Concepts, Inc. | -49.52 Million USD | 59.788% |
| Vivos Therapeutics, Inc. | -13.58 Million USD | -46.624% |
| Acutus Medical, Inc. | -81.66 Million USD | 75.612% |
| Talis Biomedical Corporation | -62 Million USD | 67.881% |
| Spectral AI, Inc. | -20.85 Million USD | 4.498% |
| Nano-X Imaging Ltd. | -60.77 Million USD | 67.23% |
| CVRx, Inc. | -41.19 Million USD | 51.659% |
| DIH Holding US, Inc. Warrants | 640.19 Thousand USD | 3210.922% |
| PetVivo Holdings, Inc. | -10.95 Million USD | -81.793% |
| Bioventus Inc. | -156.23 Million USD | 87.252% |
| Venus Concept Inc. | -37.25 Million USD | 46.534% |
| TriSalus Life Sciences, Inc. | -59.03 Million USD | 66.266% |
| LivaNova PLC | 17.54 Million USD | 213.507% |
| 908 Devices Inc. | -36.39 Million USD | 45.284% |
| Alphatec Holdings, Inc. | -186.63 Million USD | 89.329% |
| Nemaura Medical Inc. | -14.14 Million USD | -40.811% |
| NeuroPace, Inc. | -32.95 Million USD | 39.568% |
| LENSAR, Inc. | -14.38 Million USD | -38.469% |
| Apyx Medical Corporation | -18.71 Million USD | -6.429% |
| Cutera, Inc. | -162.83 Million USD | 87.769% |
| STRATA Skin Sciences, Inc. | -10.83 Million USD | -83.897% |
| BioSig Technologies, Inc. | -29.04 Million USD | 31.421% |
| Anika Therapeutics, Inc. | -82.66 Million USD | 75.908% |
| ClearPoint Neuro, Inc. | -22.08 Million USD | 9.837% |
| Integra LifeSciences Holdings Corporation | 67.74 Million USD | 129.4% |
| Axonics, Inc. | -6.08 Million USD | -227.135% |
| Outset Medical, Inc. | -172.79 Million USD | 88.474% |
| IRIDEX Corporation | -9.57 Million USD | -108.109% |
| PROCEPT BioRobotics Corporation | -105.89 Million USD | 81.193% |
| IRadimed Corporation | 17.19 Million USD | 215.839% |
| Tivic Health Systems, Inc. | -8.24 Million USD | -141.582% |
| INVO Bioscience, Inc. | -8.03 Million USD | -147.878% |
| Telesis Bio, Inc. | -47.72 Million USD | 58.268% |
| Viemed Healthcare, Inc. | 10.24 Million USD | 294.435% |
| Varex Imaging Corporation | -47.7 Million USD | 58.247% |
| Quipt Home Medical Corp. | -2.78 Million USD | -615.374% |
| Inspira Technologies Oxy B.H.N. Ltd. | -11.28 Million USD | -76.466% |
| Pulmonx Corporation | -60.84 Million USD | 67.267% |
| Dynatronics Corporation | -2.69 Million USD | -638.253% |
| Modular Medical, Inc. | -17.47 Million USD | -14.001% |
| ReShape Lifesciences Inc. | -11.38 Million USD | -74.901% |
| Semler Scientific, Inc. | 20.58 Million USD | 196.759% |
| InMode Ltd. | 197.91 Million USD | 110.063% |
| Bruker Corporation | 427.2 Million USD | 104.662% |
| Cytosorbents Corporation | -28.5 Million USD | 30.137% |
| DexCom, Inc. | 541.5 Million USD | 103.678% |
| Align Technology, Inc. | 445.05 Million USD | 104.475% |
| Viveve Medical, Inc. | -22.02 Million USD | 9.584% |
| ZimVie Inc. | -393.28 Million USD | 94.936% |
| Movano Inc. | -29.28 Million USD | 31.988% |
| Cytek Biosciences, Inc. | -12.14 Million USD | -63.945% |
| Nexalin Technology, Inc. | -4.64 Million USD | -328.42% |
| DIH Holdings US, Inc. Class A Common Stock | 640.19 Thousand USD | 3210.922% |
| Tandem Diabetes Care, Inc. | -222.61 Million USD | 91.053% |
| Profound Medical Corp. | -28.56 Million USD | 30.288% |
| Insulet Corporation | 206.3 Million USD | 109.654% |
| enVVeno Medical Corporation | -23.51 Million USD | 15.309% |
| Surmodics, Inc. | -11.54 Million USD | -72.552% |
| iCAD, Inc. | -4.84 Million USD | -310.893% |
| Nuwellis, Inc. | -20.2 Million USD | 1.45% |
| Biotricity, Inc. | -14.09 Million USD | -41.306% |
| iRhythm Technologies, Inc. | -123.4 Million USD | 83.861% |
| Aethlon Medical, Inc. | -12.2 Million USD | -63.137% |
| PAVmed Inc. | -64.17 Million USD | 68.966% |
| BIOLASE, Inc. | -20.63 Million USD | 3.47% |
| Beyond Air, Inc. | -60.24 Million USD | 66.94% |
| FONAR Corporation | 10.56 Million USD | 288.466% |
| AxoGen, Inc. | -21.71 Million USD | 8.289% |
| Vivani Medical, Inc. | -25.65 Million USD | 22.361% |
| Tactile Systems Technology, Inc. | 28.51 Million USD | 169.844% |
| Inari Medical, Inc. | -1.63 Million USD | -1117.359% |
| UFP Technologies, Inc. | 44.92 Million USD | 144.333% |
| QT Imaging Holdings, Inc. | -5.13 Million USD | -288.05% |
| Heart Test Laboratories, Inc. | -6.6 Million USD | -201.52% |
| Tenon Medical, Inc. | -15.58 Million USD | -27.822% |
| Autonomix Medical, Inc. Common Stock | -15.42 Million USD | -29.107% |
| Co-Diagnostics, Inc. | -35.33 Million USD | 43.633% |
| AdaptHealth Corp. | -678.89 Million USD | 97.066% |
| Sintx Technologies, Inc. | -8.25 Million USD | -141.143% |
| NanoVibronix, Inc. | -3.71 Million USD | -436.675% |
| Quanterix Corporation | -32.33 Million USD | 38.405% |
| Inspira Technologies Oxy B.H.N. Ltd. | -11.28 Million USD | -76.466% |
| Sensus Healthcare, Inc. | 485 Thousand USD | 4206.392% |
| Pacific Biosciences of California, Inc. | -306.73 Million USD | 93.507% |
| TransMedics Group, Inc. | -25.02 Million USD | 20.425% |
| ReWalk Robotics Ltd. | -22.13 Million USD | 10.017% |
| NeuroMetrix, Inc. | -6.52 Million USD | -205.016% |
| Hyperfine, Inc. | -44.23 Million USD | 54.98% |
| Establishment Labs Holdings Inc. | -78.5 Million USD | 74.63% |
| Biomerica, Inc. | -5.97 Million USD | -233.155% |
| Bone Biologics Corporation | -8.94 Million USD | -122.557% |
| AVITA Medical, Inc. | -39.16 Million USD | 49.153% |
| Bluejay Diagnostics, Inc. | -9.95 Million USD | -100.083% |
| Silk Road Medical, Inc | -55.74 Million USD | 64.272% |